62037-734 : Methylphenidate Hydrochloride 27 mg Oral Tablet, Film Coated, Extended Release


NDC62037-734
Labeler: Actavis Pharma, Inc.
Product Type: Human Prescription Drug
Drug Name:  Methylphenidate Hydrochloride
Dosage Form: Oral Tablet, Film Coated, Extended Release
Application #: ANDA076772
Rev. Date: 
CSA Schedule: CII (US) [1]


[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: 734
Shapes:  Oval
Colors:  Gray
Size (mm): 12
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 62037-734-01: 100 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE (62037‑734‑01)

Active Ingredients:

  • Methylphenidate Hydrochloride

Dosage Strength:

  • 27 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Fumaric Acid
  • Hypromellose 2208 (100 Mpa.s)
  • Hypromellose 2910 (5 Mpa.s)
  • Hypromellose 2910 (15 Mpa.s)
  • Lactose Monohydrate
  • Magnesium Stearate
  • Methacrylic Acid - Methyl Methacrylate Copolymer (1:1)
  • Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)
  • Talc
  • Titanium Dioxide
  • Triethyl Citrate
  • Fd&c Blue No. 2
  • Ferrosoferric Oxide
  • Ferric Oxide Yellow
  • Polyethylene Glycol 3350
  • Polyvinyl Alcohol, Unspecified
  • Ammonia
  • Propylene Glycol
  • Shellac /

Pharmaceutical Classes:

  • Central Nervous System Stimulant [EPC]
  • Central Nervous System Stimulation [PE]

Related Products:

Based on records with the same trade name.
  • 62037-725 Methylphenidate Hydrochloride 18 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 62037-726 Methylphenidate Hydrochloride 36 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 62037-727 Methylphenidate Hydrochloride 54 mg Oral Tablet, Film Coated, Extended Release by Actavis Pharma, Inc.
  • 0591-3854 Methylphenidate Hydrochloride 10 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-3862 Methylphenidate Hydrochloride 15 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-3869 Methylphenidate Hydrochloride 20 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-3873 Methylphenidate Hydrochloride 30 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-3891 Methylphenidate Hydrochloride 40 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-3895 Methylphenidate Hydrochloride 50 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0591-3902 Methylphenidate Hydrochloride 60 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 45963-200 Methylphenidate Hydrochloride 20 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 45963-201 Methylphenidate Hydrochloride 30 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 45963-202 Methylphenidate Hydrochloride 40 mg Oral Capsule, Extended Release by Actavis Pharma, Inc.
  • 0093-5292 Methylphenidate Hydrochloride 50 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5293 Methylphenidate Hydrochloride 60 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5295 Methylphenidate Hydrochloride 10 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5296 Methylphenidate Hydrochloride 20 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5297 Methylphenidate Hydrochloride 30 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5298 Methylphenidate Hydrochloride 40 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5346 Methylphenidate Hydrochloride 20 mg 24 Hr Extended Release Capsule by Teva Pharmaceuticals USA Inc
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 62037-734 QR Code

< Prev: 62037-727Next: 62037-753 >

Related Discussions:

Methylphenidate questions / generic recommendations
Can I have some information on this drug? ## I am prescribed methylphenidate/10mg, Carisoprodol/350mg and Diazepma/10 mg... 12 replies
Methylphenidate (concerta) prices
Why is the price of methylphenidate so expensive now? My doctor informed me that it is dirt cheap, and is generic. I was... 12 replies
methylphenidate hcl 20mg
pink tablet 585 ## Check your imprint again. Is there a letter or a sign or another number on it as well? ## An oval pin... 4 replies
Methylphenidate refill from APO
I have been taking Methylphenidate mps 20mg for the past few years and doing great. A couple of weeks ago I went up to g... 2 replies
methylphenidate 20mg tablets
take 1 tablet by mouth 3 times daily ## Hi will, Thanks for taking the time to share that dosing information. According ... 2 replies
Methylphenidate backorder
I live in southwest Florida and I have not been able to get my Rx in over a month now! I'm frustrated. Is anyone els... 1 reply
Methylphenidate is similar to Vyvanse?
My 8 year old is on methylphenidate 27 mg (concerta) and doing very well with it, but I have had many problems with his ... 1 reply
methylphenidate la 30 mg cap differences
Why would I get 2 different pills when I have the same prescription and same manufacturer on the bottles from the same P... 1 reply
Methylphenidate switched from blue to white tablet with CG and 00
I was on yellow 20mg, but I changed myself to blue (with my doc approval). I was DOING WELL BUT NOW the pharmacist gave ... 1 reply
methylphenidate & methyphenidate sa & sr
i am on just plain methylphenidate 20 mg tabs. they don't seem to be as effective as they used to be. i was talking ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.